Eisai reveals phase III results of breast cancer drug Halaven

Singapore: Eisai revealed its preliminary results from a recently completed phase III study of Halaven versus capecitabi...

July 10, 2012 | Tuesday | News
Daiichi faces $100 mn law suit for gender discrimination

Singapore: Six current and former female pharmaceutical sales professionals working with Daiichi Sankyo, US, have filed ...

February 13, 2013 | Wednesday | News
Takeda to acquire Envoy Therapeutics

Singapore: Takeda Pharmaceutical's wholly-owned subsidiary, Takeda America, and Envoy Therapeutics have entered into a ...

November 7, 2012 | Wednesday | News
Takeda drug gets positive CHMP opinion

Singapore: The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a...

July 23, 2012 | Monday | Regulatory
Abbott, Eisai receive approval to market Humira

Singapore: Abbott Japan and Eisai have received approval from Japan's Ministry of Health, Labor and Welfare to market Hu...

August 10, 2012 | Friday | Regulatory
Daiichi develops antibody to prevent fracture

Singapore: Daiichi Sankyo's 24-month randomized, double-blind, placebo-controlled multi-center phase III clinical trial ...

October 16, 2012 | Tuesday | News
Japan approves NDA for hyperlipidemia drug

Singapore: The Japanese Ministry of Health, Labor and Welfare has approved a new drug application (NDA) of Lotriga granu...

October 1, 2012 | Monday | News
Shionogi-ViiV Healthcare announces trial results of dolutegravir

Singapore: Initial results received from the phase III SINGLE (ING114467) study of Shionogi-ViiV Healthcare's investigat...

July 11, 2012 | Wednesday | News
What is the revenue size, range of CROs in APAC?

The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...

September 18, 2013 | Wednesday | Analysis
FIPB clears seven pharma proposals, defers three

Singapore: The Foreign Investment Promotion Board (FIPB) has cleared seven out of the ten investment proposals in the ph...

July 8, 2013 | Monday | Regulatory
Kyoto University gets patents for iPS cell technology

Singapore: Kyoto University has been granted four patents relating to its basic iPS cell technology, one in Japan and th...

October 11, 2012 | Thursday | Regulatory
Japanese MMA for Mitsubishi's diabetes drug

Singapore: Mitsubishi Tanabe Pharma and Daiichi Sankyo have announced that Mitsubishi Tanabe Pharma has received approva...

July 9, 2014 | Wednesday | Regulatory
Astellas seeks to market enzalutamide in Europe

Singapore: Japan-based Astellas Pharma has submitted a European marketing authorization application to the European Medi...

June 27, 2012 | Wednesday | Regulatory
Daiichi seeks approval of Topotecin use in children

Singapore: Daiichi Sankyo has submitted a supplemental new drug application to Japan's Ministry of Health, Labor and Wel...

November 9, 2012 | Friday | Regulatory
Astellas invests $140 mn on expansion in the US

Singapore: Tokyo-based Astellas, a pharmaceutical company, is investing $140 million to locate its headquarters for the ...

June 7, 2012 | Thursday | News
Google, Facebook, Apple launch 'Breakthrough Prize in Life Sciences'

Singapore: Mr Sergey Brin (computer scientist and co-founder of Google), Ms Anne Wojcicki (American biologist, co-founde...

February 21, 2013 | Thursday | News
New R&D center to advance rice research in Japan

Singapore: The agriculture ministry of Japan will set up a center to develop rice strains, using genetic studies, that a...

June 10, 2013 | Monday | News
Daiichi, Ranbaxy promote generics in Brazil

New Delhi: Daiichi Sankyo and Ranbaxy will work in synergy in Brazil to expand the business of both companies in the cou...

April 18, 2013 | Thursday | News